ORIC Pharmaceuticals

ORIC Pharmaceuticals

ORIC

Reported
Tuesday, February 18

Q4 2024 Earnings

(USD)ExpectedReportedSurprise $Surprise %
EPS-0.51-0.510.000.00%
Revenue-0.00--
WhatIF - Earnings
EPS Met Expectations
emptyImageAlt
ORIC Pharmaceuticals (ORIC:NASDAQ) has never met expectations before
There’s a first time for everything